Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05731570

Cognitive Rehabilitation for People With Cognitive Covid19

Cognitive Impairment in Long Covid: PhEnotyping and RehabilitatiOn (CICERO)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
University College, London · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Cognitive impairment is increasingly recognised as a major component of long Covid, and is estimated to be present in 25-75% of affected individuals. This impairment impacts quality of life and the loss of functional ability has major consequences for affected people, their families and the wider economy given people's difficulty in returning to work. This study will focus on helping people recover from cognitive Covid. This will involve use of rehabilitation strategies aimed at improving function in those cognitive functions identified in Stage 1 as being most affected, and assessing the benefit of rehabilitation on quality of life and people's ability to return to everyday function. These strategies will be co-produced in collaboration with a group of people living with cognitive Covid. At the end of Stage 2 we will produce a freely available "Covid-19 Cognitive Recovery Guide" for affected people, their close contacts and clinicians. In conclusion, cognitive impairment is frequently observed in long Covid but at present little is understood about its nature, or how it can be treated. The sheer scale of the CV19 pandemic makes this a top priority unmet need for healthcare worldwide. The aim of this study is to meet this need and to deliver a treatment plan for affected people which will help them return to normal life and working ability.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive rehabilitationSet of restorative and compensatory strategies to rehabilitate cognitive function combined with emotional regulation techniques.

Timeline

Start date
2023-02-14
Primary completion
2024-07-01
Completion
2024-09-01
First posted
2023-02-16
Last updated
2024-06-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05731570. Inclusion in this directory is not an endorsement.